Advertisement
Screener

CURIS, INC. (CRIS) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

CURIS, INC. Comprehensive Income

CURIS, INC. (CRIS) reported Comprehensive Income of -$8.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14

  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$8.58M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$24.20M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $19.36M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.73M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$7.58M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$43.62M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$47.00M.
  • CURIS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$56.75M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed
2026-06-30-$8.58M
10-Q · filed 2026-08-14
-$32.78M
10-Q · filed 2026-08-14
-$13.42M
derived: sum of 3 quarters · filed 2026-08-14
-$21.15M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$24.20M
10-Q · filed 2026-05-13
-$4.84M
derived: sum of 2 quarters · filed 2026-05-13
-$12.57M
derived: sum of 3 quarters · filed 2026-05-13
-$21.16M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$19.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$11.63M
derived: sum of 2 quarters · filed 2026-03-24
$3.03M
derived: sum of 3 quarters · filed 2026-08-14
-$7.58M
10-K · filed 2026-03-24
2025-09-30-$7.73M
10-Q · filed 2025-11-06
-$16.32M
derived: sum of 2 quarters · filed 2026-08-14
-$26.94M
10-Q · filed 2025-11-06
-$36.56M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$8.59M
10-Q · filed 2026-08-14
-$19.21M
10-Q · filed 2026-08-14
-$28.83M
derived: sum of 3 quarters · filed 2026-08-14
-$38.96M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$10.62M
10-Q · filed 2026-05-13
-$20.23M
derived: sum of 2 quarters · filed 2026-05-13
-$30.37M
derived: sum of 3 quarters · filed 2026-05-13
-$42.47M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$9.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
-$19.75M
derived: sum of 2 quarters · filed 2026-03-24
-$31.85M
derived: sum of 3 quarters · filed 2026-03-24
-$43.62M
10-K · filed 2026-03-24
2024-09-30-$10.13M
10-Q · filed 2025-11-06
-$22.23M
derived: sum of 2 quarters · filed 2025-11-06
-$34.00M
10-Q · filed 2025-11-06
-$45.59M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$12.10M
10-Q · filed 2025-08-05
-$23.87M
10-Q · filed 2025-08-05
-$35.45M
derived: sum of 3 quarters · filed 2025-08-05
-$47.53M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31-$11.77M
10-Q · filed 2025-05-06
-$23.35M
derived: sum of 2 quarters · filed 2025-05-06
-$35.43M
derived: sum of 3 quarters · filed 2025-05-06
-$47.40M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31-$11.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$23.67M
derived: sum of 2 quarters · filed 2025-03-31
-$35.63M
derived: sum of 3 quarters · filed 2025-03-31
-$47.00M
10-K · filed 2025-03-31
2023-09-30-$12.08M
10-Q · filed 2024-11-14
-$24.05M
derived: sum of 2 quarters · filed 2024-11-14
-$35.41M
10-Q · filed 2024-11-14
-$46.45M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$11.97M
10-Q · filed 2024-08-01
-$23.33M
10-Q · filed 2024-08-01
-$34.37M
derived: sum of 3 quarters · filed 2024-08-01
-$47.59M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31-$11.36M
10-Q · filed 2024-05-07
-$22.40M
derived: sum of 2 quarters · filed 2024-05-07
-$35.62M
derived: sum of 3 quarters · filed 2024-05-07
-$51.66M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$11.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
-$24.25M
derived: sum of 2 quarters · filed 2024-02-08
-$40.30M
derived: sum of 3 quarters · filed 2024-02-08
-$56.75M
10-K · filed 2024-02-08
2022-09-30-$13.22M
10-Q · filed 2023-11-02
-$29.26M
derived: sum of 2 quarters · filed 2023-11-02
-$45.71M
10-Q · filed 2023-11-02
-$59.44M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30-$16.04M
10-Q · filed 2023-08-03
-$32.49M
10-Q · filed 2023-08-03
-$46.22M
derived: sum of 3 quarters · filed 2023-08-03
-$57.27M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-$16.45M
10-Q · filed 2023-05-04
-$30.18M
derived: sum of 2 quarters · filed 2023-05-04
-$41.23M
derived: sum of 3 quarters · filed 2023-05-04
-$52.06M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$13.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$24.78M
derived: sum of 2 quarters · filed 2023-03-13
-$35.61M
derived: sum of 3 quarters · filed 2023-03-13
-$45.54M
10-K · filed 2023-03-13
2021-09-30-$11.05M
10-Q · filed 2022-11-09
-$21.88M
derived: sum of 2 quarters · filed 2022-11-09
-$31.82M
10-Q · filed 2022-11-09
-$39.34M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$10.83M
10-Q · filed 2022-08-04
-$20.77M
10-Q · filed 2022-08-04
-$28.29M
derived: sum of 3 quarters · filed 2022-08-04
-$34.26M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$9.93M
10-Q · filed 2022-05-05
-$17.45M
derived: sum of 2 quarters · filed 2022-05-05
-$23.43M
derived: sum of 3 quarters · filed 2022-05-05
-$30.14M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$7.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$13.49M
derived: sum of 2 quarters · filed 2022-02-24
-$20.20M
derived: sum of 3 quarters · filed 2022-02-24
-$29.91M
10-K · filed 2022-02-24
2020-09-30-$5.97M
10-Q · filed 2021-11-09
-$12.68M
derived: sum of 2 quarters · filed 2021-11-09
-$22.39M
10-Q · filed 2021-11-09
-$31.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$6.71M
10-Q · filed 2021-08-03
-$16.42M
10-Q · filed 2021-08-03
-$25.03M
derived: sum of 3 quarters · filed 2022-02-24
-$31.46M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$9.71M
10-Q · filed 2021-05-12
-$18.32M
derived: sum of 2 quarters · filed 2022-02-24
-$24.75M
derived: sum of 3 quarters · filed 2022-02-24
-$31.97M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$8.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$15.04M
derived: sum of 2 quarters · filed 2022-02-24
-$22.26M
derived: sum of 3 quarters · filed 2022-02-24
-$32.14M
10-K · filed 2022-02-24
2019-09-30-$6.43M
10-Q · filed 2020-11-10
-$13.65M
derived: sum of 2 quarters · filed 2020-11-10
-$23.53M
10-Q · filed 2020-11-10
-$29.47M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30-$7.21M
10-Q · filed 2020-08-04
-$17.10M
10-Q · filed 2020-08-04
-$23.04M
derived: sum of 3 quarters · filed 2020-08-04
-$30.26M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31-$9.88M
10-Q · filed 2020-05-12
-$15.82M
derived: sum of 2 quarters · filed 2020-05-12
-$23.05M
derived: sum of 3 quarters · filed 2020-05-12
-$31.71M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31-$5.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
-$13.16M
derived: sum of 2 quarters · filed 2020-03-19
-$21.82M
derived: sum of 3 quarters · filed 2020-03-19
-$32.57M
10-K · filed 2020-03-19
2018-09-30-$7.22M
10-Q · filed 2019-11-05
-$15.88M
derived: sum of 2 quarters · filed 2019-11-05
-$26.63M
10-Q · filed 2019-11-05
-$34.66M
derived: sum of 4 quarters · filed 2019-11-05
2018-06-30-$8.66M
10-Q · filed 2019-08-09
-$19.41M
10-Q · filed 2019-08-09
-$27.44M
derived: sum of 3 quarters · filed 2019-08-09
-$42.89M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$10.75M
10-Q · filed 2019-05-14
-$18.78M
derived: sum of 2 quarters · filed 2019-05-14
-$34.23M
derived: sum of 3 quarters · filed 2019-05-14
-$48.32M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$8.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
-$23.48M
derived: sum of 2 quarters · filed 2019-03-26
-$37.57M
derived: sum of 3 quarters · filed 2019-03-26
-$53.31M
10-K · filed 2019-03-26
2017-09-30-$15.45M
10-Q · filed 2018-11-01
-$29.54M
derived: sum of 2 quarters · filed 2018-11-01
-$45.28M
10-Q · filed 2018-11-01
-$56.65M
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30-$14.09M
10-Q · filed 2018-08-02
-$29.83M
10-Q · filed 2018-08-02
-$41.20M
derived: sum of 3 quarters · filed 2018-08-02
-$69.57M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$15.74M
10-Q · filed 2018-05-03
-$27.11M
derived: sum of 2 quarters · filed 2018-05-03
-$55.48M
derived: sum of 3 quarters · filed 2018-05-03
-$66.78M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31-$11.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$39.74M
derived: sum of 2 quarters · filed 2018-03-08
-$51.03M
derived: sum of 3 quarters · filed 2018-03-08
-$60.44M
10-K · filed 2018-03-08
2016-09-30-$28.38M
10-Q · filed 2017-11-07
-$39.67M
derived: sum of 2 quarters · filed 2017-11-07
-$49.08M
10-Q · filed 2017-11-07
-$62.56M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30-$11.29M
10-Q · filed 2017-08-03
-$20.70M
10-Q · filed 2017-08-03
-$34.19M
derived: sum of 3 quarters · filed 2018-03-08
-$39.68M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31-$9.41M
10-Q · filed 2017-05-04
-$9.41M
10-Q · filed 2016-05-09
-$22.90M
derived: sum of 2 quarters · filed 2018-03-08
-$28.38M
derived: sum of 3 quarters · filed 2018-03-08
-$36.51M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31-$13.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
-$18.97M
derived: sum of 2 quarters · filed 2018-03-08
-$27.10M
derived: sum of 3 quarters · filed 2018-03-08
-$58.94M
10-K · filed 2018-03-08
-$58.94M
10-K · filed 2016-02-29
2015-09-30-$5.49M
10-Q · filed 2016-11-03
-$5.49M
10-Q · filed 2015-11-09
-$13.62M
derived: sum of 2 quarters · filed 2016-11-03
-$45.46M
10-Q · filed 2016-11-03
-$45.46M
10-Q · filed 2015-11-09
-$51.16M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30-$8.13M
10-Q · filed 2016-08-04
-$8.13M
10-Q · filed 2015-08-06
-$39.97M
10-Q · filed 2016-08-04
-$39.97M
10-Q · filed 2015-08-06
-$45.67M
derived: sum of 3 quarters · filed 2017-03-09
-$51.26M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31-$31.84M
10-Q · filed 2016-05-09
-$37.54M
derived: sum of 2 quarters · filed 2017-03-09
-$43.13M
derived: sum of 3 quarters · filed 2017-03-09
-$45.01M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31-$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
-$11.29M
derived: sum of 2 quarters · filed 2017-03-09
-$13.17M
derived: sum of 3 quarters · filed 2017-03-09
-$18.73M
10-K · filed 2017-03-09
-$18.73M
10-K · filed 2015-02-24
2014-09-30-$5.58M
10-Q · filed 2015-11-09
-$7.47M
derived: sum of 2 quarters · filed 2015-11-09
-$13.03M
10-Q · filed 2015-11-09
-$17.25M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$1.89M
10-Q · filed 2015-08-06
-$7.45M
10-Q · filed 2015-08-06
-$11.66M
derived: sum of 3 quarters · filed 2016-02-29
-$13.53M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$5.56M
10-Q · filed 2015-05-07
-$9.78M
derived: sum of 2 quarters · filed 2016-02-29
-$11.64M
derived: sum of 3 quarters · filed 2016-02-29
-$12.94M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$4.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$6.08M
derived: sum of 2 quarters · filed 2016-02-29
-$7.38M
derived: sum of 3 quarters · filed 2016-02-29
-$12.34M
10-K · filed 2016-02-29
2013-09-30-$1.86M
10-Q · filed 2014-11-10
-$3.16M
derived: sum of 2 quarters · filed 2014-11-10
-$8.13M
10-Q · filed 2014-11-10
-$20.50M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$1.30M
10-Q · filed 2014-08-07
-$6.26M
10-Q · filed 2014-08-07
-$18.64M
derived: sum of 3 quarters · filed 2015-02-24
-$22.04M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$4.96M
10-Q · filed 2014-05-09
-$17.34M
derived: sum of 2 quarters · filed 2015-02-24
-$20.74M
derived: sum of 3 quarters · filed 2015-02-24
-$23.64M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31-$12.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$15.78M
derived: sum of 2 quarters · filed 2015-02-24
-$18.68M
derived: sum of 3 quarters · filed 2015-02-24
-$16.44M
10-K · filed 2015-02-24
2012-09-30-$3.40M
10-Q · filed 2013-11-12
-$6.30M
derived: sum of 2 quarters · filed 2013-11-12
-$4.06M
10-Q · filed 2013-11-12
$2.02M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$2.90M
10-Q · filed 2013-08-08
-$654.96K
10-Q · filed 2013-08-08
$5.42M
derived: sum of 3 quarters · filed 2014-03-13
$1.20M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$2.24M
10-Q · filed 2013-05-09
$8.32M
derived: sum of 2 quarters · filed 2014-03-13
$4.10M
derived: sum of 3 quarters · filed 2014-03-13
-$831.33K
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$6.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$1.86M
derived: sum of 2 quarters · filed 2014-03-13
-$3.08M
derived: sum of 3 quarters · filed 2014-03-13
-$9.87M
10-K · filed 2014-03-13
2011-09-30-$4.22M
10-Q · filed 2012-11-06
-$9.15M
derived: sum of 2 quarters · filed 2012-11-06
-$15.94M
10-Q · filed 2012-11-06
2011-06-30-$4.93M
10-Q · filed 2012-08-09
-$11.73M
10-Q · filed 2012-08-09
2011-03-31-$6.79M
10-Q · filed 2012-05-10
2010-12-31-$4.39M
10-K · filed 2013-03-13
2009-12-31-$9.91M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70